A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers
Noriko Sugino(Kyoto University), Akifumi Takaori‐Kondo(Kyoto University), Yayoi Shimazu(Kyoto University), Toshiya Inaba(Hiroshima University), Shingo Fujii(Kyoto University), Goichi Tatsumi(Kyoto University), Takayoshi Suzuki(Nagoya City University), Yuya Nagai(Kyoto University), Rieko Yamamoto(Kyoto University), Hirotaka Matsui(Hiroshima University), Masahiro Kawahara(Shiga University of Medical Science), Akinori Kanai(Frontier Medical College), Akira Andoh(Shiga University of Medical Science), Masakatsu Hishizawa(Kyoto Katsura Hospital)
Cited by 73
Related Papers
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
|Clinical Immunology|2003|491